A comprehensive view of Phase 3 Trial. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Health Canada approves Merck & Co's KEYTRUDA in combination with chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma treatment following successful Phase 3 trial
Published: April 19, 2024 by EquityBites
Phase 3 study of Roche's OCREVUS subcutaneous injection shows near-complete suppression of multiple sclerosis relapse activity and lesions; approval anticipated from FDA and EMA in 2024
Published: April 17, 2024 by F. Hoffmann-La Roche Ltd. (Roche)
Eli Lilly reports tirzepatide injectable significantly reduced sleep apnea in Phase 3 trials, achieving up to 63% reduction in the apnea-hypopnea index, a measure of sleep apnea severity; the drug also led to significant weight loss
Published: April 17, 2024 by Eli Lilly & Co.
AstraZenica's Imfinzi plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase 3 trial
Published: April 16, 2024 by AstraZeneca AB
Roche reports Phase 3 study finds Columvi, in combination with chemotherapy, significantly improves overall survival for people with relapsed or refractory diffuse large B-cell lymphoma; Roche to submit data to health authorities
Published: April 15, 2024 by F. Hoffmann-La Roche Ltd. (Roche)

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count